首页> 美国卫生研究院文献>Journal of Cancer >Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma
【2h】

Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma

机译:PET / CT骨髓FDG摄取模式对新诊断的弥漫性大B细胞淋巴瘤的预后价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: The value of 18F-fluorodeoxyglucose positron emission tomography /computed tomography (18F-FDG PET/CT) in assessing bone marrow involvement (BMI) of lymphoma remains controversial. The present study aims to evaluate the prognostic meaning of bone marrow FDG uptake pattern in PET/CT of newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients.>Materials and Methods: 193 newly diagnosed DLBCL patients were retrospectively analyzed. All patients received 6-8 cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP). The type of BM FDG uptake pattern was recorded by two blinded reviewers independently. The relationship between clinicopathologic features and BM patterns was analyzed. The prognostic value of different BM patterns was evaluated by Log-rank test and Cox-regression analysis.>Results: Out of 193 patients, 28 (15%) patients had focal BM FDG uptake higher than liver (fPET+), 18 (9%) patients showed diffuse BM uptake higher than liver (dPET+) and 147 (76%) patients had normal BM uptake (lower than liver) (nPET). BMB positive was found in 35.7% (10/28) of fPET+ patients, in 16.7% (3/18) of dPET+ patients and in 0.7% (1/147) of nPET patients. Diffuse BM pattern was associated with lower hemoglobin level and a trend of higher erythrocyte sedimentation rate (ESR). dPET+ patients had similar 3y-progression-free survival (3y-PFS) and 3y-overall survival (3y-OS) compared with nPET patients (80.5% vs 81.5%, p=0.701; 94.1% vs 90.6%, p=0.809, respectively), while fPET+ patients had worse 3y-PFS and 3y-OS compared with fPET- patients (32.7% vs 81.4%, p<0.001; 69.4% vs 90.9%, p=0.003, respectively). Multivariate analysis showed fPET+ (HR=2.270, p=0.025) and stage III/IV (HR=4.909, p=0.026) were independent predictors for PFS, but no factors were independently predictive for OS.>Conclusion: PET/CT-directed BM patterns are meaningful in predicting prognosis of newly diagnosed DLBCL patients. Focal BM pattern is an independent predictor for PFS.
机译:>目的: 18 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描( 18 F-FDG PET / CT)在评估骨髓受累中的价值淋巴瘤(BMI)仍存在争议。本研究旨在评估在新诊断的弥漫性大B细胞淋巴瘤(DLBCL)患者的PET / CT中骨髓FDG摄取模式的预后意义。>材料与方法::193例新诊断的DLBCL患者进行回顾性分析。所有患者均接受6-8个周期的利妥昔单抗加环磷酰胺,阿霉素,长春新碱和泼尼松(R-CHOP)。两名不知情的审稿人分别记录了BM FDG摄取模式的类型。分析了临床病理特征与BM模式之间的关系。通过对数秩检验和Cox回归分析评估了不同BM模式的预后价值。>结果:在193例患者中,有28例(15%)患者的局灶性BM FDG摄取高于肝脏(fPET + ),有18名(9%)患者的弥漫性BM摄取高于肝脏(dPET +),而147名(76%)患者的BM摄取正常(低于肝脏)(nPET)。在fPET +患者中35.7%(10/28),在dPET +患者中16.7%(3/18)和在0.7%(1/147)nPET患者中发现了BMB阳性。弥漫性BM模式与较低的血红蛋白水平和较高的红细胞沉降率(ESR)相关。与nPET患者相比,dPET +患者的3y无进展生存期(3y-PFS)和3y总体生存期(3y-OS)相似(80.5%vs 81.5%,p = 0.701; 94.1%vs 90.6%,p = 0.809, fPET +患者的3y-PFS和3y-OS分别比fPET-患者更差(分别为32.7%和81.4%,p <0.001; 69.4%和90.9%,p = 0.003)。多因素分析显示,fPET +(HR = 2.270,p = 0.025)和III / IV期(HR = 4.909,p = 0.026)是PFS的独立预测因子,但没有独立的因素可预测OS。>结论: PET / CT引导的BM模式对预测新诊断的DLBCL患者的预后具有重要意义。局灶性BM模式是PFS的独立预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号